|
Jun 3
|
Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet
|
|
May 10
|
Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings
|
|
May 10
|
Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 3
|
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
|
|
May 2
|
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
|
|
Apr 30
|
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
|
|
Apr 29
|
Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?
|
|
Apr 29
|
Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn
|
|
Apr 29
|
Deciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO Pharmaceutical
|
|
Apr 29
|
Deciphera Pharmaceuticals Is Being Acquired and the Stock Soars 72%
|
|
Apr 29
|
Update: Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal
|
|
Apr 29
|
Deciphera to sell for $2.4B, adding to upswing in biopharma M&A
|
|
Apr 29
|
UPDATE 2-Japan's Ono to buy US drugmaker Deciphera for $2.4 bln
|
|
Apr 29
|
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
|
|
Apr 25
|
Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Apr 24
|
Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Apr 21
|
11 Best Low Price Pharma Stocks To Invest In
|
|
Apr 9
|
Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
|
|
Mar 24
|
Companies Like Deciphera Pharmaceuticals (NASDAQ:DCPH) Are In A Position To Invest In Growth
|
|
Mar 14
|
Why Is Biogen Inc. (BIIB) Up 2.6% Since Last Earnings Report?
|